Notice ID: 657d88a638cd44e0ad0e74974781b771Special Notice
Q301--NEW - FIT automated occult blood testing
Archived on September 29, 2022. Full description on SAM.gov.
Overview
- Posted
- June 22, 2022
- Notice type
- Special Notice
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 257-NETWORK CONTRACT OFFICE 17 (36C257)
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C25722Q0770
- Notice ID
- 657d88a638cd44e0ad0e74974781b771
Description
Special Notice Special Notice Page 2 of 2 Special Notice *= Required Field Special Notice Page 1 of 2 DESCRIPTION Special Notice Notice of Intent to Award Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm fixed price BPA (base period of 12 months with three 12-month options) to POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC for the procurement of two (2) Fecal Immunochemical Test analyzer by cost per Test (CPT) agreement. The contractor shall provide rental of two (2) OC Auto Sensor io Analyzers and all reagents/consumables/service and scheduled maintenance on a cost-per-test (CPT) basis for Amarillo and Lubbock Pathology and Laboratory Medicine Service for 48 months. The contractor shall provide one-day training on-site. Items included in this notice are in *Attachment 1 (all pricing TBD). The proposed sole source procurement will be made by a pricing agreement with POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC, based upon pricing from their VA NAC FSS contract. The requesting activity states that currently, the laboratories of both Amarillo VAHCS and Lubbock CBOC have SAIL numbers that are not up to par as they should be according to National data. Therefore, PolyMedco OC Auto Sensor io Analyzer and all testing supplies/service and maintenance will require a new contract for the Amarillo P&LMS laboratories in Amarillo, TX, and in Lubbock, TX. This methodology has been utilized throughout VISN17 with little to no complaints, using VA FSS contract 36F79720D0016. According to the National Cancer Institute, iFOBT is more sensitive and specific for colorectal cancer screening than the alternative method of guaiac occult blood testing. The sole source justification request submitted by the requesting activity states that a sole source is required for this base plus three (3) options. Market research was conducted, and no other vendor was found to be capable of providing this requirement. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this Notice; however, all responsible sources may submit a capability statement (with their SAM UID), proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the Government. If no affirmative written response is received within five (5) days from the publication of this Notice, a BPA will be issued to POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC without any further notice. The anticipated statutory authority permitting other than full and open competition requirement is 41 USC 3304(a)(1), as implemented by FAR 8.405-6, Limiting Sources. Notice: Interested firms must respond directly to the POC email address listed in this Notice for consideration. *See Attachment 1
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C25722Q0770- Special NoticeCurrentJun 22, 2022
Q301--NEW - FIT automated occult blood testing
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
BD Micro Reagents and Service | - | Awarded | Open |
CTX BD Micro Reagents and Service Contract | - | Awarded | Open |
NTX blood bank cost per test | - | Awarded | Open |
THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available. This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy. I. General Information - Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX. 75216 - Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas. - Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS. II. Description of Requirement Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. The contemplated purchase includes, at a minimum: The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. Estimated Yearly Requirements: Item # Description/Part Number* Qty Unit 1 Z401U, ALBAcyte A1 Cells 52 EA 2 Z406U, ALBAcyte A2 Cells 13 EA 3 Z411U, ALBAcyte B Cells 52 EA 4 Z4411U-1, ALBAcyte IgG Sensitized Cells (weak) 26 EA 5 Z473U, ALBAcyte Antibody ID Panel (16-cell) 7 EA 6 Z482U, ALBAcyte C3 Coated Red Blood Cells 13 EA Period of Performance: Base Year: 05/01/2027-04/30/2028 Option Year 1: 05/01/2028-04/30/2029 Option Year 2: 05/01/2029-04/30/2030 Option Year 3: 05/01/2030-04/30/2031 Option Year 4: 05/01/2031-04/30/2032 Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216. III. Performance requirements: Performance Requirements: The following are required: Packing and Delivery: All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award. The reagents shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of the reagents. Vendor must be approved by the FDA and shall provide documentation of approval. Vendor must have a defined Quality plan, and Adequate supplies available. IV. Submission Instructions Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time. - Teresa Arzola  - Email: Teresa.arzola@va.gov  - Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS  No telephone inquiries will be accepted. Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought. | - | Market Research | 11/05/2026 |
Electrophoresis CPT Sources Sought Notice This notice is for planning purposes only and shall not be considered an invitation for bid, request for quotation, request for proposal, or as an obligation of the government to acquire any products or services. Responses to this notice will be used for informational purposes only. No entitlement to payment of direct or indirect costs from the government will arise as a result from a response to this announcement. No contract will be awarded from this notice. The information requested in this notice will be used to determine if there are sufficient socioeconomic small business concerns that are capable of performing the work described for the requirement. The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office (NCO) 17 is seeking sources for the following procurement: Electrophoresis CPT; Contractor shall provide a fully automated, gel electrophoresis instrument that can perform both serum and urine electrophoresis (SPEP/UPEP), immunofixation (SIFE/UIFE) and Immunotyping (IT) to identify monoclonal and polyclonal gammopathies for the Pathology & Laboratory Medicine Service of the South Texas Veterans Health Care System (STVHCS), Audie L. Murphy Memorial VA Hospital, located at 7400 Merton Minter Blvd., San Antonio, TX 78229. See attached Statement of Work. BACKGROUND South Texas Veterans Health Care System Pathology & Laboratory Medicine Services (P&LMS) 7400 Merton Minter Blvd. San Antonio, TX 78229 DESCRIPTION OF SERVICES The South Texas Veterans Health Care System (STVHCS) has a continued need for Serum and Urine Protein Electrophoresis, IFE, and IT instrumentation. The contractor shall provide a fully automated, gel electrophoresis instrument that can perform both serum and urine electrophoresis (SPEP/UPEP), immunofixation (SIFE/UIFE) and Immunotyping (IT) to identify monoclonal and polyclonal gammopathies. The Sebia instruments Capillarys and Hydrasys have been in use in the STVHCS Chemistry Laboratory 2016. See Price/Cost Schedule and Attachment A within the Statement of Work (SOW) for lists of estimated testing needs. (Quantities are estimates only). See attached SOW for the performance requirements. RESPONSE If interested, please provide the following information in a response: 1. Name of Company 2. Point of Contact; name, phone number and email address 3. SAM UEI # or DUNS number 4. Company socio-economic status (i.e., Small Business, SDVOSB/VOSB) 5. Capability Statement The information provided in a response to this notice may be used in developing an acquisition approach. Interested parties are responsible for adequately marking any proprietary or competitive sensitive information that is provided in a response. Submission Instructions: Interested parties who consider themselves qualified to perform must respond to the notice to be considered by 10:00 AM CST, September 22, 2026. All responses under this Sources Sought Notice must be emailed to Jose.Campa@va.gov. Telephone inquiries will not be accepted or acknowledged and no feedback or evaluations will be provided to companies regarding their submissions. | - | Market Research | 09/22/2026 |
Additional Details
Solicitation Number
36C25722Q0770
Archive Date
Sep 29, 2022
Office Address
San Antonio, TX, 78240